269 related articles for article (PubMed ID: 25030389)
1. Standardization and quantification in PET/CT imaging: tracers beyond FDG.
Antunovic L; Rodari M; Rossi P; Chiti A
PET Clin; 2014 Jul; 9(3):259-66. PubMed ID: 25030389
[TBL] [Abstract][Full Text] [Related]
2. Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.
Gámez-Cenzano C; Pino-Sorroche F
PET Clin; 2014 Apr; 9(2):117-27. PubMed ID: 25030277
[TBL] [Abstract][Full Text] [Related]
3. PET and PET-CT. State of the art and future prospects.
Fanti S; Franchi R; Battista G; Monetti N; Canini R
Radiol Med; 2005; 110(1-2):1-15. PubMed ID: 16163136
[TBL] [Abstract][Full Text] [Related]
4. [FDG-PET/CT in oncology. German Guideline].
Krause BJ; Beyer T; Bockisch A; Delbeke D; Kotzerke J; Minkov V; Reiser M; Willich N
Nuklearmedizin; 2007; 46(6):291-301. PubMed ID: 18084685
[TBL] [Abstract][Full Text] [Related]
5. FDG PET/CT in oncology: "raising the bar".
Patel CN; Goldstone AR; Chowdhury FU; Scarsbrook AF
Clin Radiol; 2010 Jul; 65(7):522-35. PubMed ID: 20541652
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of PET/CT with tracers other than F-18-FDG in oncology: an evidence-based review.
Treglia G; Sadeghi R; Del Sole A; Giovanella L
Clin Transl Oncol; 2014 Sep; 16(9):770-5. PubMed ID: 24647843
[TBL] [Abstract][Full Text] [Related]
7. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
8. Clinical PET in oncology: not only FDG.
Nanni C; Rubello D; Al-Nahhas A; Fanti S
Nucl Med Commun; 2006 Sep; 27(9):685-8. PubMed ID: 16894321
[No Abstract] [Full Text] [Related]
9. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development.
Hallett WA; Maguire RP; McCarthy TJ; Schmidt ME; Young H
IDrugs; 2007 Nov; 10(11):791-6. PubMed ID: 17968761
[TBL] [Abstract][Full Text] [Related]
10. Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials.
Graham MM; Wahl RL; Hoffman JM; Yap JT; Sunderland JJ; Boellaard R; Perlman ES; Kinahan PE; Christian PE; Hoekstra OS; Dorfman GS
J Nucl Med; 2015 Jun; 56(6):955-61. PubMed ID: 25883122
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of oncological [11C]radiopharmaceuticals for clinical PET.
Lodi F; Malizia C; Castellucci P; Cicoria G; Fanti S; Boschi S
Nucl Med Biol; 2012 May; 39(4):447-60. PubMed ID: 22172394
[TBL] [Abstract][Full Text] [Related]
12. Advances in metabolic imaging for surgical oncology.
Iagaru A; Quon A
Surg Oncol Clin N Am; 2007 Apr; 16(2):273-92. PubMed ID: 17560512
[TBL] [Abstract][Full Text] [Related]
13. Non-[18F]FDG PET in clinical oncology.
Groves AM; Win T; Haim SB; Ell PJ
Lancet Oncol; 2007 Sep; 8(9):822-30. PubMed ID: 17765191
[TBL] [Abstract][Full Text] [Related]
14. Utility of 18F-FDG PET/CT for staging NK/T-cell lymphomas.
Wu HB; Wang QS; Wang MF; Li HS; Zhou WL; Ye XH; Wang QY
Nucl Med Commun; 2010 Mar; 31(3):195-200. PubMed ID: 20009963
[TBL] [Abstract][Full Text] [Related]
15. Preliminary study of 11C-choline PET/CT for T staging of locally advanced nasopharyngeal carcinoma: comparison with 18F-FDG PET/CT.
Wu HB; Wang QS; Wang MF; Zhen X; Zhou WL; Li HS
J Nucl Med; 2011 Mar; 52(3):341-6. PubMed ID: 21321282
[TBL] [Abstract][Full Text] [Related]
16. Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases.
Pantaleo MA; Nannini M; Lopci E; Castellucci P; Maleddu A; Lodi F; Nanni C; Allegri V; Astorino M; Brandi G; Di Battista M; Boschi S; Fanti S; Biasco G
Int J Oncol; 2008 Sep; 33(3):443-52. PubMed ID: 18695872
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
18. PET and PET/CT in endocrine tumours.
Dudczak R; Traub-Weidinger T
Eur J Radiol; 2010 Mar; 73(3):481-93. PubMed ID: 20089377
[TBL] [Abstract][Full Text] [Related]
19. FDG and Beyond.
De Ruysscher D; Haustermans K; Thorwarth D
Recent Results Cancer Res; 2016; 198():163-73. PubMed ID: 27318686
[TBL] [Abstract][Full Text] [Related]
20. [Hybrid PET/CT in cancer imaging].
Seppänen M; Kajander S; Kemppainen J; Minn H
Duodecim; 2011; 127(11):1117-27. PubMed ID: 21755803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
